Spot Trading’s Sage Therapeutics SAGE Stock Holding History

Spot Trading’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,650	Closed	-$193K	–	4211
2015 Q2	$193K	Buy	+2,650	New	+$170K	﹤0.01%	2736

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's SAGE Position: Q3 2015 in Review

Spot Trading sold out of Sage Therapeutics (SAGE) in Q3 2015, closing a stake of 2,650 shares — an estimated $193K sold.

Spot Trading first reported a position in SAGE in Q2 2015 and held it in 1 quarter. The position peaked at $193K in Q2 2015. 134 funds tracked by Wall St. Rank hold SAGE as of Q3 2015.

Spot Trading reported no remaining Sage Therapeutics position as of Q3 2015 after selling out during the quarter.
Spot Trading sold 2,650 Sage Therapeutics shares in Q3 2015, an estimated $193K.
Spot Trading first reported a position in Sage Therapeutics in Q2 2015 and held it in 1 quarter.
Spot Trading's Sage Therapeutics position peaked at $193K in Q2 2015.
134 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2015.

Based on Spot Trading's 13F filing for Q3 2015, filed 3 Nov 2015.